CFDE Data Portal | Search CAAP1

	Label	Description
	CAAP1 Gene (Entity type)	ENSG00000120159 - caspase activity and apoptosis inhibitor 1
	CAAP1 associations Collection (Entity type)	Associations for CAAP1_associations
	CAAP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CAAP1 HUMAN Protein (Entity type)	Caspase activity and apoptosis inhibitor 1
	CAAP1 MOUSE Protein (Entity type)	Caspase activity and apoptosis inhibitor 1
	CAAP1 BOVIN Protein (Entity type)	Caspase activity and apoptosis inhibitor 1
	GSE158632 3 V 5 OXYQUINOLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 6 V 10 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE132369,GSE132371 3 V 0 CCCP HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE129542 BAT1 knockdown RNA Small Interfering 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

CAAP1

ENSG00000120159 - caspase activity and apoptosis inhibitor 1

CAAP1 associations

Associations for CAAP1_associations

CAAP1 associations.tsv

A file from IDG as part of the Harmonizome project

CAAP1 HUMAN

Caspase activity and apoptosis inhibitor 1

CAAP1 MOUSE

Caspase activity and apoptosis inhibitor 1

CAAP1 BOVIN

Caspase activity and apoptosis inhibitor 1

GSE158632 3 V 5 OXYQUINOLINE HUMAN DN

A Gene Set from LINCS

GSE239844 6 V 10 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

GSE132369,GSE132371 3 V 0 CCCP HUMAN UP

A Gene Set from LINCS

GSE129542 BAT1 knockdown RNA Small Interfering 0 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.